[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fVnvTgIrVPKbTEyW1AQ0PbS2I-zPbxaaNSv8giE-r4XI":3,"$fu-qdFK3Jb2-AmHysKB6VmiFpRnHDHCWDIID9pekFlAc":52},{"company":4,"items":17,"total":14},{"id":5,"slug":6,"company_name":7,"website_url":8,"country_code":9,"source_name":10,"source_url":11,"profile_summary":8,"legal_name":8,"legal_form":8,"registry_court":8,"registry_number":8,"vat_id":8,"impressum_address":8,"enrichment_sources_json":8,"enrichment_model":8,"enrichment_updated_at":8,"enrichment_error":8,"first_seen_at":12,"updated_at":13,"award_count":14,"total_value_eur":15,"latest_award_at":16},30630,"recordati-rare-diseases-germany-gmbh","Recordati Rare Diseases Germany GmbH",null,"DEU","ted-v3","https://ted.europa.eu/de/notice/-/detail/436706-2025","2026-06-11 09:57:39","2026-07-20 02:00:52",3,1,"2025-09-29T00:00:00.000Z",[18,38,49],{"award_id":19,"tender_id":20,"source_name":10,"source_award_id":21,"source_url":22,"award_notice_type":23,"award_date":24,"publication_date":16,"lot_number":25,"contract_title":26,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":33,"buyer_name":34,"region_code":35,"cpv_code":36,"tender_published_at_utc":37,"tender_deadline_utc":8},506427,58142,"634636-2025","https://ted.europa.eu/de/notice/-/detail/634636-2025","can-standard","2024-02-01T00:00:00.000Z","LOT-0001","Mesalazin, ATC A07EC02","Recordati Pharma GmbH","HRB 727718","EUR",0.97,"public","free","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Mesalazin, ATC A07EC02 für die Zeit 01.02.2024 - 31.01.2026","DAK-Gesundheit","DE-HH","33600000","2025-09-28T22:00:00.000Z",{"award_id":39,"tender_id":40,"source_name":10,"source_award_id":41,"source_url":11,"award_notice_type":23,"award_date":8,"publication_date":42,"lot_number":8,"contract_title":43,"winner_name":7,"winner_identifier":8,"winner_country":8,"value_eur":8,"currency":8,"confidence":44,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":45,"buyer_name":46,"region_code":47,"cpv_code":36,"tender_published_at_utc":48,"tender_deadline_utc":8},67123,70759,"436706-2025","2025-07-04T00:00:00.000Z","Bekanntmachung vergebener Aufträge nach §130 a Abs. 8 SGB V und §130 c SGB V zu dem Wirkstoff Pasireotid",0.92,"Deutschland – Arzneimittel – Bekanntmachung vergebener Aufträge nach §130 a Abs. 8 SGB V und §130 c SGB V zu dem Wirkstoff Pasireotid","GWQ ServicePlus AG","DE-NW","2025-07-03T22:00:00.000Z",{"award_id":50,"tender_id":40,"source_name":10,"source_award_id":41,"source_url":11,"award_notice_type":23,"award_date":8,"publication_date":42,"lot_number":51,"contract_title":43,"winner_name":7,"winner_identifier":28,"winner_country":9,"value_eur":15,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":45,"buyer_name":46,"region_code":47,"cpv_code":36,"tender_published_at_utc":48,"tender_deadline_utc":8},242075,"LOT-0000",{"company_slug":6,"years":53,"award_count":14,"top_buyers":54,"yearly_trend":63},5,[55,59],{"buyer_name":46,"buyer_key":56,"award_count":57,"total_value_eur":15,"share_count":58},"gwq-serviceplus-ag",2,0.667,{"buyer_name":34,"buyer_key":60,"award_count":15,"total_value_eur":61,"share_count":62},"dak-gesundheit",0,0.333,[64],{"year":65,"award_count":14},2025]